好色先生

好色先生

Explore the latest content from across our publications
Join The AAN

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

Hepatic safety of galcanezumab in patients with migraine: Results of three Phase 2 double-blind placebo-controlled trials
Headache
P2 - (-)
164
Authors/Disclosures

PRESENTER 		No disclosure on file
No disclosure on file
Vladimir Skljarevski No disclosure on file
Shufang Wang No disclosure on file
No disclosure on file